Fadi Zarrad
- Oncology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 10%
- Surgery
- Pharmaceutical Science top 2%
- Co-authors
- Bernd NeumaierPhilipp KrapfBoris D. ZlatopolskiyElizaveta A. UrusovaWolfgang P. FendlerMichael NaderJohannes ZischlerLale Umutlu
- Topics
- Peptidase Inhibition and Analysis (11 papers)Medical Imaging Techniques and Applications (7 papers)Radiopharmaceutical Chemistry and Applications (6 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Fadi Zarrad
19 papers receiving 576 citations
Peers
Comparison fields: 5 of 51
- Oncology 274
- Radiology, Nuclear Medicine and Imaging 239
- Cancer Research 169
- Surgery 157
- Pharmaceutical Science 152
Countries citing papers authored by Fadi Zarrad
This map shows the geographic impact of Fadi Zarrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Zarrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Zarrad more than expected).
Fields of papers citing papers by Fadi Zarrad
This network shows the impact of papers produced by Fadi Zarrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Zarrad. The network helps show where Fadi Zarrad may publish in the future.
Co-authorship network of co-authors of Fadi Zarrad
This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Zarrad. A scholar is included among the top collaborators of Fadi Zarrad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Zarrad. Fadi Zarrad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 6 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 18 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 3 | |
| 10 | 72 | |
| 11 | 56 | |
| 12 | 12 | |
| 13 | 74 | |
| 14 | 41 | |
| 15 | 1 | |
| 16 | 34 | |
| 17 | 29 | |
| 18 | 114 | |
| 19 | 89 |
About Fadi Zarrad
Fadi Zarrad is a scholar working on Pharmaceutical Science, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 19 papers that have together received 583 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (11 papers), Medical Imaging Techniques and Applications (7 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Pharmaceutical Science (152 citations), Cancer Research (169 citations) and Radiology, Nuclear Medicine and Imaging (239 citations). Fadi Zarrad has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Bernd Neumaier, Philipp Krapf, Boris D. Zlatopolskiy, Elizaveta A. Urusova, Wolfgang P. Fendler, Michael Nader, Johannes Zischler, Lale Umutlu, Lukas Kessler and Nader Hirmas. Their work appears in journals such as Scientific Reports, Chemistry - A European Journal and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.